462 related articles for article (PubMed ID: 10752211)
1. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
[TBL] [Abstract][Full Text] [Related]
2. Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism.
Verga U; Bergamaschi S; Cortelazzi D; Ronzoni S; Marconi AM; Beck-Peccoz P
Clin Endocrinol (Oxf); 2009 May; 70(5):798-802. PubMed ID: 18771569
[TBL] [Abstract][Full Text] [Related]
3. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
4. Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy.
Abalovich M; Vázquez A; Alcaraz G; Kitaigrodsky A; Szuman G; Calabrese C; Astarita G; Frydman M; Gutiérrez S
Thyroid; 2013 Nov; 23(11):1479-83. PubMed ID: 23731335
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
6. Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?
Gursoy A; Ozduman Cin M; Kamel N; Gullu S
Int J Clin Pract; 2006 Jun; 60(6):655-9. PubMed ID: 16805747
[TBL] [Abstract][Full Text] [Related]
7. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study.
Rosario PW
Clin Endocrinol (Oxf); 2010 May; 72(5):685-8. PubMed ID: 20447066
[TBL] [Abstract][Full Text] [Related]
8. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
[TBL] [Abstract][Full Text] [Related]
9. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
[TBL] [Abstract][Full Text] [Related]
10. [Optimization of levothyroxine treatment. Dosage dependence on the existing parenchymal mass, age, body weight and fasting intake].
Wenzel KW
Dtsch Med Wochenschr; 1986 Sep; 111(36):1356-62. PubMed ID: 3743448
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.
Braclik M; Marcisz C; Giebel S; Orzeł A
Thyroid; 2008 May; 18(5):545-50. PubMed ID: 18466078
[TBL] [Abstract][Full Text] [Related]
13. [Combination therapy of endemic goiter with two different thyroxine/iodine combinations].
Klemenz B; Förster G; Wieler H; Kahaly G; Kaiser KP; Hansen C; Willkomm P; Ruhlmann J
Nuklearmedizin; 1998 May; 37(3):101-6. PubMed ID: 9604230
[TBL] [Abstract][Full Text] [Related]
14. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.
Bell RJ; Rivera-Woll L; Davison SL; Topliss DJ; Donath S; Davis SR
Clin Endocrinol (Oxf); 2007 Apr; 66(4):548-56. PubMed ID: 17371474
[TBL] [Abstract][Full Text] [Related]
15. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
16. Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism.
Adrees M; Gibney J; El-Saeity N; Boran G
Clin Endocrinol (Oxf); 2009 Aug; 71(2):298-303. PubMed ID: 19094068
[TBL] [Abstract][Full Text] [Related]
17. Subclinical hypothyroidism is characterized by increased QT interval dispersion among women.
Bakiner O; Ertorer ME; Haydardedeoglu FE; Bozkirli E; Tutuncu NB; Demirag NG
Med Princ Pract; 2008; 17(5):390-4. PubMed ID: 18685279
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological functions and metabolic aspects in subclinical hypothyroidism: the effects of L-thyroxine.
Baldini M; Colasanti A; Orsatti A; Airaghi L; Mauri MC; Cappellini MD
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):854-9. PubMed ID: 19389454
[TBL] [Abstract][Full Text] [Related]
19. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hypothyroidism].
Massol J
Rev Prat; 1998 Nov; 48(18):2027-33. PubMed ID: 9881014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
